TONIX PHARMACEUTICALS HLDG C
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for TONIX PHARMACEUTICALS HLDG C cs, CUSIP 890260706.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for TONIX PHARMACEUTICALS HLDG C cs, CUSIP 890260706.